Traders should monitor the completion of entity formations and the Taiwan investment, as successful execution could validate the new ECRUX strategy and drive investor interest. The shift from motion picture services to a venture investment platform represents a material business model transformation with potential for outsized returns if the regenerative medicine and Japanese market plays succeed.
Price Chart
Executive Summary
Harrison Global Holdings Inc. announced a strategic restructuring to establish the ECRUX global investment platform, including the formation of U.S. and Cayman Islands subsidiaries, the acquisition of CSI Japan Co., Ltd. for JPY 300,000, and a 51% controlling investment in a Taiwan-based regenerative medicine firm for up to JPY 5,000,000. These moves signal a pivot toward a venture investment focus under the ECRUX brand, with key leadership appointments and a clear expansion roadmap across Asia.
Key Facts
- Board approved formation of ECRUX Inc. (U.S.) and ECRUX Holdings Inc. (Cayman Islands), each with up to $500,000 authorized capital.
- Bloomz Limited to become a subsidiary of ECRUX Holdings Inc. within 90 days.
- Acquisition of 100% of CSI Japan Co., Ltd. for approximately JPY 300,000, to be renamed ECRUX Venture Partners Japan Inc., expected within 30 days.
- Investment of up to JPY 5,000,000 by ECRUX Venture Partners, LLC into RIKEN Taiwan Immune Regenerative Medicine Inc., resulting in 51% ownership and renaming to ECRUX Venture Partners Taiwan Inc., targeted within 60 days.
- Ryoshin Nakade and Kim Jung to serve as proposed representatives across new entities.
- Filing made under Form 6-K, indicating material developments by this foreign private issuer.
Financial Impact
Up to $37,500 (JPY 5,000,000) in new investments, with minimal upfront capital outlay given the small acquisition price of JPY 300,000 (~$2,250). The restructuring consolidates control and positions the company for scalable venture returns.
Risk Factors
- Execution risk in establishing new subsidiaries and completing acquisitions on schedule.
- Limited financial scale of current transactions may not translate to immediate earnings impact.
- Forward-looking nature of announcements with no guarantees of successful integration or returns.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001984014-26-000009 |
| Document: 0001984014-26-000009-index-headers.html | 0001984014-26-000009 |
| Document: 0001984014-26-000009-index.html | 0001984014-26-000009 |
| Document: 0001984014-26-000009.txt | 0001984014-26-000009 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 27d ago | 6-K | $0.000200 $0.000300 | ▼ −50.00% | ▼ −48.05% | $0.0150 (−7400.00%) |
Jun 15, 2026 19w ago | 25-NSE | $0.000700 $0.000700 | · 0.00% | ▼ −2.56% | $0.0150 (−2042.86%) |
Apr 1, 2026 29w ago | 6-K | $0.0117 $0.0112 | ▼ −4.27% | ▼ −7.89% | $0.0150 (+28.21%) |
Apr 1, 2026 29w ago | 6-K | $0.0117 $0.0112 | ▼ −4.27% | ▼ −7.89% | $0.0150 (+28.21%) |
Apr 1, 2026 29w ago | 6-K | $0.0117 $0.0112 | ▼ −4.27% | ▼ −7.89% | $0.0150 (+28.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers